Kanto Chemical Co. Inc. has begun selling its ciKIC iPS medium, which is designed to keep human induced pluripotent stem…...
Please subscribe to read the full story.
iPS
Asahi Kasei to Mass-Produce iPS-Derived Regenerative Medicine Product
Asahi Kasei Corp. (TYO:3407) is starting to establish infrastructure for manufacturing regenerative medicine products. The company has invested several hundred…...
Please subscribe to read the full story.
Green Peptide Looks to Rejuvenate iPS-Derived T Cells
Having acquired Advanced Immunotherapy Co. Ltd. (AIT) as a subsidiary in December 2016, Green Peptide Co. Ltd. (TYO:4594) is now…...
Please subscribe to read the full story.
